(rivaroxaban)
This information is intended for US healthcare professionals to access current scientific information about Janssen products. It is prepared by Janssen Medical Information and is not intended for promotional purposes, nor to provide medical advice.
Last Updated: 06/06/2024
Please refer to the following sections of the enclosed Full Prescribing Information that are relevant to your inquiry: DESCRIPTION.
XARELTO tablets, granules for oral suspension and their excipients do not contain wheat, rye, barley, oats, spelt, or kamut. XARELTO excipients do not contain gluten as an ingredient.1-
Mannitol, an inactive ingredient in the granules for oral suspension, can be derived from wheat. Wheat gluten content is < 20 mg/kg.3
Since XARELTO tablets, granules for oral suspension, and their excipients are not tested for gluten, the possibility of cross-contamination with gluten during the manufacturing process of the individual ingredients cannot be eliminated.1,3
1 | Data on File. Patient Safety and Compliance Information (EXC and IMC)-Xarelto 10 mg. Janssen Scientific Affairs, LLC.; 2022. |
2 | |
3 | |
4 |